Sentiment · FY2026 Q1
What companies say about each other on earnings calls — extracted verbatim from public transcripts. Mentions from the newest quarter are a Pro feature.
“3M gave themselves a contractual option to again step up our cost in 2027, and we've shared that, that's about a 100 basis point headwind for us if that in fact happens.”
3M holds a contractual option to raise the raw-material costs it charges Solventum in 2027, a potential ~100bp margin headwind; the companies are discussing an alternative.
“We can continue to buy from 3M as a raw material supplier with that intellectual property or we can go to another chemical manufacturer to use them as well.”
Solventum, spun off from 3M, retains a long-term raw-material supply agreement with 3M but owns transferable IP rights, so it can source from 3M or alternative chemical manufacturers.
“We're pleased to report another solid quarter as we navigate the separation from 3M and transform our balance sheet following the sale of the Purification and Filtration business.”
Solventum continues to execute its corporate separation from former parent 3M, including winding down transition service agreements.
“our portion is related to AFFF and compare it to the 3M announcement earlier in New Jersey in that the 5% range, so right in the middle of that 3% to 7%.”
DuPont benchmarks its AFFF-related share of the New Jersey PFAS settlement against 3M's earlier New Jersey settlement to show its liability lands within the expected 3%-7% range.
“As a reminder, gross margins include a headwind associated with the 3M supply agreement, which was more than offset by improved sales mix and programmatic savings.”
Solventum's supply agreement with former parent 3M remains a gross-margin headwind as it separates operations, though it was offset by mix and savings this quarter.
“Our current quarter results include approximately 100 basis points of increased cost paid to 3M as part of the supply agreement when comparing year-over-year.”
Solventum's transition supply agreement with 3M (its former parent) added roughly 100 basis points of cost, pressuring gross margin year-over-year.
“Results include approximately 100 basis points of increased cost paid to 3M as part of the supply agreement.”
Post-spinoff, 3M continues to generate revenue from Solventum via a transition supply agreement, which Solventum expects to keep weighing on its gross margin as the higher-cost agreement annualizes into 2025.
“largely from the wind-down of transition services agreements related to Solventum”
3M is winding down the transition services agreements tied to its former spinoff Solventum, a modest drag on 3M corporate income as that separation relationship runs off.
“And yes, so we did have a settlement with the state of New Jersey, both for a specific site, which we did not own. It's a Chemours DuPont site, but there was some liability there as well as statewide claims.”
3M's New Jersey PFAS settlement covers a specific site it did not own that is jointly associated with DuPont and Chemours liability, alongside separate statewide claims.
“And yes, so we did have a settlement with the state of New Jersey, both for a specific site, which we did not own. It's a Chemours DuPont site, but there was some liability there as well as statewide claims.”
3M's New Jersey PFAS settlement covers a specific site it did not own that is jointly associated with Chemours and DuPont liability, alongside separate statewide claims.
“This performance was driven by benefits from volume leverage, productivity, Solventum transition service agreement, cost reimbursements, and restructuring, partially offset by FX and investments to drive growth in the business.”
3M's full-year margin expansion was aided by transition service agreement cost reimbursements from Solventum, an ongoing financial benefit tied to the spinoff.
“Earlier in the year, we spun off our Healthcare Business Group as Solventum and we settled two significant legal matters.”
3M frames the 2024 spinoff of its Healthcare Business Group as Solventum as a completed structural milestone for the transition year.
| Analyst | Firm | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Julian Mitchell | Barclays | 12 (8%) |
| Scott Davis | Melius Research | 12 (0%) |
| Jeff Sprague | Vertical Research Partners | 12 (8%) |
| Andy Kaplowitz | Citigroup | 12 (0%) |
| Nicole DeBlase | Deutsche Bank | 11 (0%) |
| Joe O'Dea | Wells Fargo | 11 (0%) |
| Andy Obin | Bank of America | 10 (10%) |
| Steve Tusa | JPMorgan | 10 (20%) |
| Amit Mehrotra | UBS | 10 (0%) |
| Nigel Coe | Wolfe Research | 9 (33%) |
| Firm | Analysts | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| JPMorgan | 2 | 12 (17%) |
| Melius Research | 1 | 12 (0%) |
| Citigroup | 1 | 12 (0%) |
| Vertical Research Partners | 1 |
$3M closed FY2025 with 3% adjusted organic growth for the full year, adjusted operating margins of 24.8% expanding 420 basis points, and adjusted EPS of $7.81 up 22% year-over-year, completing a strong first full year as a standalone company. Management introduced FY2026 guidance of $8.05-8.45 in adjusted EPS with 2-4% organic growth, while advancing its organic growth culture, restructuring program, and supply chain regionalization to address ongoing tariff uncertainty.
Margin | Demand | Revenue Growth | Guidance Reliability | Cost Pressure | Macroeconomic | Pricing | Trade Tariffs | |
|---|---|---|---|---|---|---|---|---|
| 2024Q4 | 8 | 3 | 3 | 4 | 5 | 4 | 2 | |
| 2025Q1 | 4 | 5 | 1 | 3 | 3 | 2 | 1 | 9 |
| 2025Q2 | 7 | 6 | 5 | 4 | 3 | 1 | 3 | 4 |
| 2025Q3 | 7 | 3 | 4 | 3 | 1 | 2 | ||
| 2025Q4 | 5 | 7 | 4 | 1 | 1 | 3 | 2 | 1 |
| 2026Q1 | 3 | 8 | 3 | 3 | 3 | 4 | 4 |
| '24Q4 | '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | |
|---|---|---|---|---|---|---|
| Margin | 8 | 4 | 7 | 7 | 5 | 3 |
| Demand | 3 | 5 | 6 | 3 | 7 | 8 |
| Revenue Growth | 3 | 1 | 5 | 4 | 4 | 3 |
| Guidance Reliability | 4 | 3 | 4 | 3 | 1 | 3 |
| Cost Pressure | 5 | 3 | 3 | 1 | 1 | 3 |
| Macroeconomic | 4 | 2 | 1 | 3 | 4 | |
| Pricing | 2 | 1 | 3 | 2 | 2 | 4 |
| Trade Tariffs | 9 | 4 | 1 |
| 12 (8%) |
| Barclays | 1 | 12 (8%) |
| Deutsche Bank | 1 | 11 (0%) |
| Wells Fargo | 1 | 11 (0%) |
| Bank of America | 1 | 10 (10%) |
| Company | Score | Trend | Rev YoY |
|---|---|---|---|
MMM 3M Company | 6 | +1.3% | |
| HON Honeywell International Inc. | 5 | -6.9% |